You thought the Shark Tank was tough…wait until you enter the the BioHealth Capital Region Crab Trap!
Submit your application for the opportunity to be named the company with the most commercial potential at the 2020 BioHealth Regional Forum, $10,000, and MORE!
Application Deadline: March, 20th 2020
Finalists will be announced: April 3rd, 2020
Finalist Presentations BioHealth Capital Region Forum Event: April 15th, 2020
08/25/2026
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the FDA has accepted the New Drug Application (NDA) for ralinepag to treat PAH. The FDA has set a Prescription Drug User Fee Act target action date of June 24, 2027. Ralinepag has not been approved for use in any indication by the …
08/19/2026
ATCC has been selected by the Centers for Disease Control and Prevention (CDC) for a new contract to support serological assays for the detection and characterization of influenza viruses. The award, valued at up to $7.3 million over the 5-year contract period (contract 75D30126C21030), will support CDC’s National Center for Immunization and Respiratory Diseases, Influenza …
08/18/2026
Nanochon, a medical device company developing Chondrograft™, a novel patented implant for the treatment of articular cartilage defects of the knee, today announced that it has received regulatory approval from Panamá’s Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá. The study will evaluate the safety and performance of Chondrograft™ in patients …